Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,192 | 907 | 99.7% |
| Education | $42.77 | 7 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,559 | 132 | $0 (2024) |
| Novo Nordisk Inc | $1,960 | 98 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,869 | 100 | $0 (2024) |
| Lilly USA, LLC | $1,709 | 83 | $0 (2024) |
| PFIZER INC. | $1,651 | 112 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $734.41 | 43 | $0 (2022) |
| Merck Sharp & Dohme LLC | $728.56 | 58 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $703.81 | 40 | $0 (2024) |
| Astellas Pharma US Inc | $498.56 | 30 | $0 (2024) |
| Amgen Inc. | $326.21 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,126 | 98 | Lilly USA, LLC ($335.86) |
| 2023 | $1,804 | 91 | AbbVie Inc. ($482.86) |
| 2022 | $2,064 | 103 | ABBVIE INC. ($781.28) |
| 2021 | $1,890 | 112 | AbbVie Inc. ($633.39) |
| 2020 | $1,815 | 113 | AstraZeneca Pharmaceuticals LP ($249.94) |
| 2019 | $1,891 | 115 | AstraZeneca Pharmaceuticals LP ($264.85) |
| 2018 | $2,099 | 117 | AstraZeneca Pharmaceuticals LP ($355.58) |
| 2017 | $2,546 | 165 | AstraZeneca Pharmaceuticals LP ($305.49) |
All Payment Transactions
914 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $29.70 | General |
| Category: Narcoplepsy | ||||||
| 12/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Biological | ||||||
| 12/12/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Hematology | ||||||
| 12/06/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: VACCINES | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Gastroenterology | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: DIABETES | ||||||
| 11/13/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $31.14 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $33.90 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $31.19 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $31.94 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Obesity | ||||||
| 10/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: PAIN | ||||||
| 10/12/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/01/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Obesity | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,251 | 3,374 | $392,183 | $133,530 |
| 2022 | 20 | 2,101 | 3,079 | $340,499 | $109,630 |
| 2021 | 26 | 2,313 | 3,324 | $362,422 | $121,300 |
| 2020 | 32 | 2,641 | 3,759 | $395,396 | $117,048 |
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 280 | 783 | $166,225 | $73,909 | 44.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 92 | 92 | $27,324 | $13,268 | 48.6% |
| 82306 | Vitamin d-3 level | Office | 2023 | 159 | 165 | $19,470 | $4,787 | 24.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 18 | 21 | $11,865 | $4,754 | 40.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $8,175 | $4,214 | 51.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 231 | 447 | $10,728 | $3,739 | 34.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 48 | 48 | $7,440 | $3,633 | 48.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 24 | $8,825 | $3,571 | 40.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 191 | 269 | $26,900 | $3,519 | 13.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 182 | 209 | $19,019 | $3,440 | 18.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 214 | 331 | $33,100 | $3,417 | 10.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 194 | 241 | $9,158 | $1,834 | 20.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 182 | 208 | $15,808 | $1,832 | 11.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 48 | 48 | $1,920 | $1,662 | 86.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 74 | 74 | $3,330 | $1,579 | 47.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 79 | 150 | $6,900 | $1,420 | 20.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 56 | 63 | $7,182 | $1,135 | 15.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $700.00 | $484.82 | 69.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 39 | 42 | $3,108 | $428.05 | 13.8% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 17 | 21 | $1,470 | $280.56 | 19.1% |
| 80076 | Liver function blood test panel | Office | 2023 | 27 | 28 | $812.00 | $224.28 | 27.6% |
| 83550 | Iron binding capacity | Office | 2023 | 17 | 21 | $966.00 | $179.97 | 18.6% |
| 83540 | Iron level | Office | 2023 | 17 | 21 | $1,134 | $133.14 | 11.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 36 | 39 | $624.00 | $85.80 | 13.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 244 | 662 | $142,375 | $62,947 | 44.2% |
About Dr. Scott Whittaker, M.D
Dr. Scott Whittaker, M.D is a Internal Medicine healthcare provider based in Alexandria, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1235281684.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Whittaker, M.D has received a total of $16,235 in payments from pharmaceutical and medical device companies, with $2,126 received in 2024. These payments were reported across 914 transactions from 71 companies. The most common payment nature is "Food and Beverage" ($16,192).
As a Medicare-enrolled provider, Whittaker has provided services to 9,306 Medicare beneficiaries, totaling 13,536 services with total Medicare billing of $481,508. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Alexandria, VA
- Active Since 01/17/2007
- Last Updated 02/17/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1235281684
Products in Payments
- UBRELVY (Drug) $988.83
- FARXIGA (Drug) $973.61
- JARDIANCE (Drug) $858.98
- VRAYLAR (Drug) $818.63
- Ozempic (Drug) $805.86
- XARELTO (Drug) $658.94
- TRULICITY (Drug) $543.28
- MOUNJARO (Drug) $528.49
- CHANTIX (Drug) $439.64
- QULIPTA (Drug) $390.34
- SYNTHROID (Drug) $365.42
- BREZTRI (Drug) $351.57
- SYMBICORT (Drug) $349.71
- JANUVIA (Drug) $297.03
- Saxenda (Drug) $293.30
- REXULTI (Drug) $291.96
- Wegovy (Drug) $277.50
- ELIQUIS (Drug) $247.59
- PREVNAR 20 (Biological) $241.06
- EMGALITY (Drug) $214.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Alexandria
Dr. Benjamin Close, M.d, M.D
Internal Medicine — Payments: $493,843
Dr. Kanna Posina, M.d, M.D
Internal Medicine — Payments: $33,667
Robert Freedman, M.d, M.D
Internal Medicine — Payments: $18,837
Wayne Wu, M.d, M.D
Internal Medicine — Payments: $18,212
Michael Mitchell, M.d, M.D
Internal Medicine — Payments: $16,622
Dr. Laura Robinette, Md, MD
Internal Medicine — Payments: $15,826